Premier Inc.
03/14/2026 | Press release | Archived content
Bipartisan bill would give president new authority on medical good trade deals
*:last-child]:mb-0 [&>*:last-child]:pb-0 [&>p]:font-normal text-left [&>.prm-button-bar]:justify-start [&_.portable-text-link]:font-semibold [&_.portable-text-link]:underline [&_.prm-button-bar_a]:no-underline [&_li]:text-light-gray [&_p]:text-light-gray">
Fierce Healthcare examines new bipartisan legislation that would give the president expanded authority to negotiate trade agreements for medical goods, including adjusting tariffs with trusted partners. The proposed Medical Supply Chain Resiliency Act aims to strengthen the U.S. healthcare supply chain following pandemic-era disruptions, while also raising questions about the balance between tariff flexibility and affordability. The article also highlights industry perspectives, including support from Premier Inc., which emphasized the importance of bipartisan action to improve supply chain resilience.
Read the full story on Fierce Healthcare.
Premier Inc. published this content on March 14, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on March 23, 2026 at 16:27 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]